| Jamie Hoffman-rosenfeld, MD | |
|
Schneider Children's Hospital, 269-01 76th Avenue, New Hyde Park, NY 11040 | |
| (718) 470-3204 | |
| Not Available |
| Full Name | Jamie Hoffman-rosenfeld |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | Schneider Children's Hospital, New Hyde Park, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053481119 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 154923 (New York) | Primary |
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
An Emory University study shows some of the first direct evidence of a process required for epigenetic reprogramming between generations – a finding that could shed more light on the mechanisms of fertilization, stem-cell formation and cloning.
Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine.
Research in the Linus Pauling Institute at Oregon State University suggests that some natural food compounds, which previously have been studied for their ability to prevent cancer, may be able to play a more significant role in treating it - working side-by-side with the conventional drugs that are now used in chemotherapy.
Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that it has received funding approval in the amount of €3 million from the German Federal Ministry of Education and Research for the so-called CancerMark project.
Reprogramming asthma-promoting immune cells in mice diminishes airway damage and inflammation, and could potentially lead to new treatments for people with asthma, researchers have found.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jamie Hoffman-rosenfeld, MD Schneider Children's Hospital, 269-01 76th Avenue, New Hyde Park, NY 11040 Ph: (718) 470-3204 | Jamie Hoffman-rosenfeld, MD Schneider Children's Hospital, 269-01 76th Avenue, New Hyde Park, NY 11040 Ph: (718) 470-3204 |
News Archive
An Emory University study shows some of the first direct evidence of a process required for epigenetic reprogramming between generations – a finding that could shed more light on the mechanisms of fertilization, stem-cell formation and cloning.
Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine.
Research in the Linus Pauling Institute at Oregon State University suggests that some natural food compounds, which previously have been studied for their ability to prevent cancer, may be able to play a more significant role in treating it - working side-by-side with the conventional drugs that are now used in chemotherapy.
Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today that it has received funding approval in the amount of €3 million from the German Federal Ministry of Education and Research for the so-called CancerMark project.
Reprogramming asthma-promoting immune cells in mice diminishes airway damage and inflammation, and could potentially lead to new treatments for people with asthma, researchers have found.
› Verified 9 days ago
Oscar Andres Muniz-seda, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 26901 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-3000 | |
Robert Katz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 410 Lakeville Rd, Suite 108, New Hyde Park, NY 11042 Phone: 516-465-4377 Fax: 516-465-5399 | |
Dr. Yehuda Shapir, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: Lijmc - Dept Of Pediatric Cardiology, 269-01 76th Avenue, New Hyde Park, NY 11040 Phone: 718-470-7350 | |
Alpna Aggarwal, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 26901 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-3204 | |
Nadia Rana, Pediatrics Medicare: Medicare Enrolled Practice Location: 2800 Marcus Ave Ste 202, New Hyde Park, NY 11042 Phone: 516-216-1777 | |
Nina Skaria, NP Pediatrics Medicare: Medicare Enrolled Practice Location: 1991 Marcus Ave, New Hyde Park, NY 11042 Phone: 516-472-3700 | |
Susana Castro-alcaraz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Sch Division Of Neonatal Medicine, 269 01 76th Avenue, New Hyde Park, NY 11040 Phone: 718-470-3440 |